Total Payments
$2,080
2024 Payments
$28.60
Companies
22
Transactions
161
Payment Breakdown by Category
Food & Beverage$2,080 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,080 | 161 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $414.15 | 30 | $0 (2022) |
| GlaxoSmithKline, LLC. | $350.78 | 33 | $0 (2019) |
| PFIZER INC. | $231.13 | 21 | $0 (2019) |
| Lilly USA, LLC | $185.02 | 19 | $0 (2022) |
| Astellas Pharma US Inc | $155.32 | 9 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $153.07 | 10 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $125.27 | 11 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $92.64 | 7 | $0 (2022) |
| ABBVIE INC. | $64.73 | 3 | $0 (2022) |
| Allergan, Inc. | $61.57 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.60 | 1 | Astellas Pharma US Inc ($28.60) |
| 2023 | $83.73 | 4 | Astellas Pharma US Inc ($43.01) |
| 2022 | $425.42 | 27 | Novo Nordisk Inc ($171.00) |
| 2021 | $146.06 | 9 | Biohaven Pharmaceuticals, Inc. ($45.26) |
| 2020 | $95.42 | 5 | Allergan, Inc. ($43.17) |
| 2019 | $306.35 | 25 | GlaxoSmithKline, LLC. ($116.32) |
| 2018 | $573.95 | 52 | GlaxoSmithKline, LLC. ($149.81) |
| 2017 | $420.20 | 38 | Lilly USA, LLC ($108.34) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: Biological | ||||||
| 11/15/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Biological | ||||||
| 10/26/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Biological | ||||||
| 01/10/2023 | Ultragenyx Pharmaceutical Inc. | CRYSVITA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 01/10/2023 | Ultragenyx Pharmaceutical Inc. | CRYSVITA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 12/07/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Diabetes | ||||||
| 11/14/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/10/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Diabetes | ||||||
| 11/07/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Diabetes | ||||||
| 10/19/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/19/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Diabetes | ||||||
| 10/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Diabetes | ||||||
| 09/14/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/30/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: PRIMARY CARE | ||||||
| 08/17/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 08/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/19/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Obesity | ||||||
| 07/12/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/06/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Diabetes | ||||||
| 05/31/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/03/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
About Dr. Timothy Maynard, M.D
Dr. Timothy Maynard, M.D is a Family Medicine healthcare provider based in Gatesville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396706388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Maynard, M.D has received a total of $2,080 in payments from pharmaceutical and medical device companies, with $28.60 received in 2024. These payments were reported across 161 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,080).
Ad
Practice Information
- Specialty Family Medicine
- Location Gatesville, TX
- Active Since 03/29/2006
- Last Updated 08/03/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1396706388
Products in Payments
- TRELEGY ELLIPTA (Drug) $172.25
- CHANTIX (Drug) $161.33
- VRAYLAR (Drug) $126.30
- Rybelsus (Drug) $121.05
- Ozempic (Drug) $110.03
- JANUVIA (Drug) $101.22
- ENTRESTO (Drug) $92.64
- SOLIQUA 100/33 (Biological) $91.91
- BREO (Drug) $71.76
- Veozah (Drug) $71.61
- TRULICITY (Drug) $65.75
- Tresiba (Drug) $64.22
- Victoza (Drug) $63.94
- NURTEC ODT (Drug) $58.85
- SHINGRIX (Biological) $56.16
- EMGALITY (Drug) $43.42
- MYRBETRIQ (Drug) $43.07
- CRYSVITA (Drug) $40.72
- Myrbetriq (Drug) $40.64
- BASAGLAR (Drug) $38.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Gatesville
Dr. Diedra Wuenschel, D.o, D.O
Family Medicine — Payments: $5,523
Family Medicine $5,523
Adrian Dirk, Md, MD
Family Medicine — Payments: $5,275
Family Medicine $5,275
Zoe Walker, Md, MD
Family Medicine — Payments: $3,539
Family Medicine $3,539
Jacinto Obregon, Md, MD
Family Medicine — Payments: $1,588
Family Medicine $1,588
Dr. Timothy Dannemiller, M.d, M.D
Family Medicine — Payments: $1,460
Family Medicine $1,460
Dr. Charles Rismyhr, Md, MD
Family Medicine — Payments: $311.10
Family Medicine $311.10